Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CENT | CLOV |
|---|---|---|
| Price | $39.70 | $4.68 |
| Change today | ▼ 0.28% | ▲ 6.85% |
| Market cap | $2.48B | $2.49B |
| Return, 3 months | -7.2% | -6.4% |
| Return, year to date | +23.5% | +99.1% |
| Return, 1 year | +27.3% | +78.6% |
| P/E (TTM) | 14.7 | -93.6 |
| P/B | 1.4 | 6.6 |
| P/E percentile vs own 5y | – | 0th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | -8.2% | +55.6% |
| Net profit growth (YoY) | -5.7% | +364.7% |
| Gross margin | 35.9% | 20.6% |
| Operating margin | 14.3% | 3.8% |
| Net margin | 10.2% | 3.8% |
| Return on equity | – | – |
| Analyst target vs. price | +24.7% | +17.5% |
| Analyst buy share | 50% | 67% |
| RSI (14) | 40 | 58 |
| 30-day volatility | 17.0% | 51.8% |
| Max drawdown, 1 year | -16.4% | -55.5% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
